Search results
Results: 77,249
Number of items: 77,249
-
Kolader, M., Peerbooms, P. G. H., van Voorst Vader, P. C., van Bergen, J. E. A. M., Fennema, J. S. A., & de Vries, H. J. C. (2004). Toename van flurochinolonresistentie bij Neisseria gonorrhoeae onder bezoekers van de soa-polikliniek in Amsterdam; cefotaxim nu als eerste keuze aanbevolen voor ongecompliceerde gonorroe. Nederlands Tijdschrift voor Geneeskunde, 148(43), 2129-2132. -
Baud, J. M., & Rutten, R. A. (2004). Introduction. International Review of Social History, 49(S12), 1-18. https://doi.org/10.1017/S0020859004001610 -
van der Geest, K. A. M., & Dietz, T. (2004). A literature survey about risk and vulnerability in drylands, with a focus on the Sahel. In A. J. Dietz, R. Ruben, & A. Verhagen (Eds.), The Impact of Climate Change on Drylands, with a focus on West Africa (pp. 117-146). (Environment & Policy; No. 39). Kluwer Academic Publishers. -
Wilcox, W. R., Banikazemi, M., Guffon, N., Waldek, S., Lee, P., Linthorst, G. E., Desnick, R. J., & Germain, D. P. (2004). Long-term safety and efficacy of enzyme replacement therapy for Fabry disease. American Journal of Human Genetics, 75(1), 65-74. https://doi.org/10.1086/422366 -
Voskuijl, W. P., de Lorijn, F., Verwijs, W., Hogeman, P., Heijmans, J., Makel, W., Taminiau, J. A. J. M., & Benninga, M. A. (2004). PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. Gut, 53(11), 1590-1594. https://doi.org/10.1136/gut.2004.043620 -
Matera, I., Bachetti, T., Puppo, F., Duca, M., Morandi, F., Casiraghi, G. M., Cilio, M. R., Hennekam, R. C. M., Hofstra, R., Schöber, J. G., Ravazzolo, R., Ottonello, G., & Ceccherini, I. (2004). PHOX2B mutations and polyalanine expansions correlate with the severity of the respiratory phenotype and associated symptoms in both congenital and late onset Central Hypoventilation syndrome. Journal of Medical Genetics, 41(5), 373-380.
Page 6779 of 7725